B

Braxia Scientific Corp
OTC:BRAXF

Watchlist Manager
Braxia Scientific Corp
OTC:BRAXF
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $51.1k

Cash Flow Statement

Cash Flow Statement
Braxia Scientific Corp

Rotate your device to view
Cash Flow Statement
Currency: CAD
Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Operating Cash Flow
Net Income
(85)
(171)
(89)
(92)
(92)
(11)
(12)
(15)
(15)
(12)
(13)
(13)
(11)
(10)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
1
1
0
0
Change in Deffered Taxes
0
0
0
0
0
0
(0)
0
0
0
(0)
0
0
0
Stock-Based Compensation
0
0
3
3
4
5
2
2
2
1
1
1
0
0
Other Non-Cash Items
81
162
81
82
83
4
7
9
8
6
7
6
6
6
Change in Working Capital
0
1
2
3
2
1
0
1
(0)
(2)
(1)
(1)
(1)
1
Cash from Operating Activities
(4)
N/A
(8)
-120%
(5)
+35%
(8)
-48%
(7)
+12%
(5)
+18%
(5)
+16%
(6)
-27%
(7)
-20%
(7)
-7%
(7)
0%
(7)
+0%
(6)
+22%
(3)
+55%
Investing Cash Flow
Capital Expenditures
0
0
0
0
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
0
(0)
Other Items
(1)
(3)
(1)
(1)
(1)
(0)
(1)
(1)
(1)
(1)
(0)
(0)
0
0
Cash from Investing Activities
(1)
N/A
(3)
-100%
(1)
+49%
(1)
-2%
(1)
-1%
(0)
+74%
(1)
-77%
(1)
-67%
(2)
-74%
(1)
+20%
(1)
+21%
(1)
+34%
0
N/A
(0)
N/A
Financing Cash Flow
Net Issuance of Common Stock
14
28
14
14
14
0
3
3
3
3
1
0
0
0
Net Issuance of Debt
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other
0
1
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
14
N/A
29
+100%
14
-50%
14
+0%
14
0%
0
-99%
3
+2 551%
3
0%
3
0%
3
-3%
1
-53%
1
-1%
1
0%
1
-3%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
Net Change in Cash
10
N/A
18
+93%
8
-56%
6
-30%
7
+16%
(6)
N/A
(2)
+57%
(4)
-68%
(6)
-46%
(6)
-4%
(7)
-17%
(7)
+6%
(4)
+34%
(1)
+69%
Free Cash Flow
Free Cash Flow
(4)
N/A
(8)
-120%
(5)
+35%
(8)
-48%
(7)
+12%
(5)
+18%
(5)
+16%
(6)
-33%
(8)
-30%
(8)
-5%
(8)
-1%
(8)
+4%
(6)
+29%
(3)
+54%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett